FDA Inspection 1068673 — Heartsine Technologies Inc
The FDA completed an inspection of Heartsine Technologies Inc on May 3, 2018 in Newtown, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 3, 2018
- Fiscal Year
- 2018
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Newtown, PA (United States)
Additional Details
Postmarket Audit Inspections